MP22-11 CHANGES IN COMORBIDITY AFTER TREATMENT WITH GONADOTROPHIN RELEASING AGONISTS VERSUS ANTI-ANDROGEN MONOTHERAPY IN MEN WITH ADVANCED NON-METASTATIC PROSTATE CANCER | Zendy

AI Assistant Blog Pricing

MP22-11 CHANGES IN COMORBIDITY AFTER TREATMENT WITH GONADOTROPHIN RELEASING AGONISTS VERSUS ANTI-ANDROGEN MONOTHERAPY IN MEN WITH ADVANCED NON-METASTATIC PROSTATE CANCER

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.